Dr. J. Todd Kuenstner is an Associate Professor and the Medical Director of Clinical Laboratories at Temple University Hospital. He received degrees from George Washington University and Albany Medical College, and completed his residency training at Walter Reed Army Medical Center in Washington, DC. He is also the Chairman and co-founder of AVIcure Bioscience, and has served as the Principle Investigator for Human Para’s MAP and Crohn’s disease testing study.

Here, Dr. Kuenstner reports preliminary results of the MAP/Crohn’s disease testing study, which found that viable MAP organisms were detected by phage assay in 54.6% of the 194 subjects in the study. The study will remain blinded until March 2019, when all testing is complete. Publication is expected in July 2019.

Thank you to everyone who has made this study possible. To all of the Crohn’s and control subject participants, to the researchers who have donated their time and expertise, and to our Human Para community who have donated time and resources to this endeavor. A special note of thanks to Valerie Joly of Crohn’s Warrior Fights and the Denver, NC community for hosting a golf tournament which raised a whopping $22,678.32, and funded the majority of the study. We couldn’t have done it without all of you!